Unstable Heteroresistance as a Stepping Stone to Stable Resistance via Compensatory Mutations
- 1Uppsala University
Abstract
Antibiotic heteroresistance, a trait in which a drug-susceptible population harbors a rare resistant subpopulation, has been presented as an unstable intermediate state on the way to classic stable antibiotic resistance. However, the timescales and pathways under which this could occur has not been examined. Extending a recombination-based model of copy- heteroresistance to include compensatory mutations, with rates and costs from experimental estimates, we simulated populations across thousands of generations of growth with {beta}-lactam exposure. In the first days a founder population survives by one of two paths, either amplifying the resistance gene to a high copy-number or gaining compensatory mutations and staying at low copy-number. However, both paths converge over weeks to months on the same low-copy compensated state, which would be indistinguishable from classical resistance. Importantly, the ending state would provide no information as to the route taken: an isolate sequenced afterward carries no sign of the intermediate amplified state. With the parameters estimated and across a wide range of parameters, we find that amplification-mediated heteroresistance can be a transient stepping stone across lethal selection that leaves no sequence trace in surviving isolates.
Related
- Frequency of macrolide resistance-associated mutations in Mycoplasma genitalium: a multicenter molecular analysis based in Brazil.
- Fitness costs of antibiotic resistance mutations in rich media do not reliably predict those in infection-like environments
- A heterologous expression system allows rapid testing and discovery of resistance-conferring mutations from multiple pathogenic fungi
- Spontaneous wbbL and waaG mutations selected by phage vB_EcoP_P61425 confer resistance and attenuate virulence in ExPEC
- Stepwise evolution of tigecycline resistance in Enterococcus hirae through early IS1216E-mediated tet(L) amplification and subsequent rpsJ mutations
BibTeX
@misc{berryhill2026unstable,
title = {{Unstable Heteroresistance as a Stepping Stone to Stable Resistance via Compensatory Mutations}},
author = {B. A. Berryhill and D. I. Andersson},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.08.756632},
url = {https://www.biorxiv.org/content/10.64898/2026.10.08.756632v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Unstable Heteroresistance as a Stepping Stone to Stable Resistance via Compensatory Mutations
AU - B. A. Berryhill
AU - D. I. Andersson
PY - 2026
DA - 2026/10/08
PB - bioRxiv
DO - 10.64898/2026.10.08.756632
UR - https://www.biorxiv.org/content/10.64898/2026.10.08.756632v1
AB - Antibiotic heteroresistance, a trait in which a drug-susceptible population harbors a rare resistant subpopulation, has been presented as an unstable intermediate state on the way to classic stable antibiotic resistance. However, the timescales and pathways under which this could occur has not been examined. Extending a recombination-based model of copy- heteroresistance to include compensatory mutations, with rates and costs from experimental estimates, we simulated populations across thousands of generations of growth with {beta}-lactam exposure. In the first days a founder population survives by one of two paths, either amplifying the resistance gene to a high copy-number or gaining compensatory mutations and staying at low copy-number. However, both paths converge over weeks to months on the same low-copy compensated state, which would be indistinguishable from classical resistance. Importantly, the ending state would provide no information as to the route taken: an isolate sequenced afterward carries no sign of the intermediate amplified state. With the parameters estimated and across a wide range of parameters, we find that amplification-mediated heteroresistance can be a transient stepping stone across lethal selection that leaves no sequence trace in surviving isolates.
ER -